Vir Biotechnology (VIR) Asset Utilization Ratio (2019 - 2026)

Vir Biotechnology's Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 0.06 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 319.29% year-over-year to 0.06; the TTM figure through Mar 2026 stood at 0.06 (up 319.29% YoY), while the FY2025 annual figure was 0.06, up 27.63% from the prior year.
• Asset Utilization Ratio came in at 0.06 for Q1 2026 at Vir Biotechnology, down from 0.07 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.96 in Q1 2022 to a low of 0.02 in Q2 2025.
• A 5-year average of 0.24 and a median of 0.06 in 2023 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio jumped 1909.12% in 2022 and plunged 94.02% in 2023, its largest moves.
• Vir Biotechnology's Asset Utilization Ratio stood at 0.62 in 2022, then slumped by 92.96% to 0.04 in 2023, then increased by 10.39% to 0.05 in 2024, then jumped by 41.26% to 0.07 in 2025, then fell by 4.67% to 0.06 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.06, 0.07, and 0.02 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison